Banks Hold Ground Post-Trump Cannabis Rescheduling
Image: AI Generated (Freepik)
Legislation

Banks Hold Ground Post-Trump Cannabis Rescheduling

Cannabis industry faces financial roadblocks despite policy shifts

David Okonkwo
David Okonkwo

Senior Policy Correspondent

January 10, 2026

HOOK

In a surprising turn of events, major U.S. banks continue to keep their distance from the $32 billion legal cannabis industry, even after an executive order from President Donald Trump aimed at rescheduling marijuana. This steadfast refusal is causing frustration at the highest levels of government, according to reports, highlighting a significant disconnect between policy intentions and industry realities.

Key Takeaways

  • Major banks remain hesitant to engage with cannabis businesses.
  • Trump's rescheduling order has not swayed financial institutions.
  • The cannabis industry continues to face significant banking challenges.

THE STORY

Background on Cannabis Banking Challenges

The ongoing struggle for cannabis businesses to secure reliable banking services is not a new issue. Historically, the legal cannabis industry has been marred by a series of financial hurdles, largely due to marijuana's previous classification under the Controlled Substances Act. This classification equated cannabis with drugs like heroin, deterring banks from engaging with cannabis businesses due to regulatory fears and potential legal repercussions.

Rescheduling and Its Implications

In December 2023, President Trump issued an executive order that rescheduled marijuana, ostensibly to pave the way for better business opportunities and alleviate some of the industry's financial strain. The move was met with cautious optimism by some industry stakeholders. "We hoped this would open more doors, but clearly, more work needs to be done," said a cannabis policy expert who wished to remain anonymous.

Continued Financial Barriers

Despite the executive order, the major financial institutions have not shifted their stance. Policy experts suggest that the banks' reluctance is rooted in a need for clearer federal legislation that explicitly protects them when engaging with cannabis businesses. "Banks are inherently risk-averse institutions," noted John Fincher, a financial analyst specializing in cannabis markets. "Without concrete legal assurances, it's unlikely we'll see a change in their approach."

Industry's Call for Legislative Action

The cannabis industry has long advocated for the SAFE Banking Act, a piece of legislation designed to offer protections to financial institutions that serve cannabis businesses. However, despite bipartisan support, it has repeatedly stalled in Congress. Until comprehensive federal legislation is enacted, banks are likely to remain on the sidelines, leaving cannabis businesses to rely on alternative, often costly, financial services.

WHY THIS MATTERS

The implications are clear: the cannabis industry cannot fully thrive without access to traditional banking services. This persistent financial isolation hampers growth, increases operational costs, and limits the industry's potential to contribute to the economy. For consumers, this could mean higher prices and fewer options, as businesses struggle to manage their finances through less conventional means.

WHAT'S NEXT

Looking ahead, the focus will likely shift back to Congress as advocates push for renewed discussions on the SAFE Banking Act. Policymakers and industry stakeholders will be watching closely to see if further legislative efforts can bridge the gap left by the executive order. Analysts suggest that until such federal measures are enacted, the cannabis industry's financial challenges will persist.


This article is based on original reporting by mjbizdaily.com.

Original Source

This article is based on reporting from MJBizDaily.

Read the original article

Original title: "Big banks still refusing cannabis despite Trump marijuana rescheduling"

Related Stories

More from David Okonkwo

View all articles